Literature DB >> 8655606

Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse.

J E Dennis1, A I Caplan.   

Abstract

Primary cultures were initiated from marrow, spleen, and bone explants of an adult H-2Kb-tsA58 transgenic mouse (immortomouse). All cultures were initiated in immortalizing conditions, and an additional marrow culture was first incubated for 1 week in standard conditions and then switched to immortalizing conditions. Marrow cells immediately immortalized were designated the marrow immediate population (MIP); those immortalized after 1 week were termed the marrow delayed population (MDP). MIP and MDP cells both contained a mixture of fibroblastic or flattened cells, and the MIP cells contained an additional subpopulation of adipocytic (Oil Red-O positive) cells. Alkaline phosphatase expression was induced by dexamethasone (10(-7) M) in MDP cells while MIP, spleen, and bone explant cells had only a low level of expression. MDP and MIP cells differentiated into bone when combined with porous calcium phosphate ceramics and implanted subcutaneously into nude mice while bone- and spleen-derived cells did not. Clones were isolated from the MDP and MIP cell populations and tested for differentiated phenotypes. Some MIP-derived clones exhibited adipocytic characteristics while MDP-derived subclones were negative. Histologic examination of porous ceramic implanted clones showed that all of the clones had osteogenic potential. Clones exposed to either dexamethasone, human recombinant bone morphogenetic protein-2, or horse serum plus hydrocortisone showed differences in expression of adipocytic or osteogenic markers. These immortalized cultures have retained both adipocytic and osteogenic potential even after 1 year of continuous culture, and provide a model system for clonal analysis of the developmental potential of marrow-derived mesenchymal precursor cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655606     DOI: 10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent.

Authors:  Paula Dore-Duffy; Afroza Mehedi; Xueqian Wang; Michael Bradley; Richard Trotter; Alexander Gow
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

2.  Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Authors:  Hiroto Miwa; Yoshiki Hashimoto; Keiji Tensho; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2011-10-15       Impact factor: 2.058

3.  Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.

Authors:  Paul Lin; Diego Correa; Thomas J Kean; Amad Awadallah; James E Dennis; Arnold I Caplan
Journal:  Mol Ther       Date:  2013-09-25       Impact factor: 11.454

4.  Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

Authors:  Anne-Laure Leblond; Patrice Naud; Virginie Forest; Clothilde Gourden; Christine Sagan; Bénédicte Romefort; Eva Mathieu; Bruno Delorme; Christine Collin; Jean-Christophe Pagès; Luc Sensebé; Bruno Pitard; Patricia Lemarchand
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

5.  Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature.

Authors:  Gokhan Yilmaz; Shantel Vital; Cigdem Erkuran Yilmaz; Karen Y Stokes; J Steven Alexander; D Neil Granger
Journal:  Stroke       Date:  2011-01-21       Impact factor: 7.914

6.  Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue.

Authors:  Gokhan Yilmaz; J Steven Alexander; Cigdem Erkuran Yilmaz; D Neil Granger
Journal:  Exp Transl Stroke Med       Date:  2010-05-28

7.  Glucocorticoid receptor antagonist and siRNA prevent senescence of human bone marrow mesenchymal stromal cells in vitro.

Authors:  Na Wei; Yang Yu; Vijaya Joshi; Thomas Schmidt; Fang Qian; Aliasger K Salem; Clark Stanford; Liu Hong
Journal:  Cell Tissue Res       Date:  2013-08-21       Impact factor: 5.249

8.  Proteomic analysis of human bone marrow mesenchymal stem cells transduced with human telomerase reverse transcriptase gene during proliferation.

Authors:  G P Huang; Z J Pan; J P Huang; J F Yang; C J Guo; Y G Wang; Q Zheng; R Chen; Y L Xu; G Z Wang; Y M Xi; D Shen; J Jin; J F Wang
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

9.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

10.  Effect of Subcultivation of Human Bone Marrow Mesenchymal Stem on their Capacities for Chondrogenesis, Supporting Hematopoiesis, and Telomea Length.

Authors:  Masaki Nakahara; Mutsumi Takagi; Takako Hattori; Shigeyuki Wakitani; Toshiomi Yoshida
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.